Charles River Laboratories stock trades below its yearly high
Published on 09/23/2026 at 17:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Charles River Laboratories stock was trading at USD 285.94 on the NYSE on September 23, 2026 at 11:35 a.m. ET, up 0.29 percent and 5.7 percent below its 52-week high of USD 303.31. The price action places the contract research organization near the upper end of its yearly range, while its latest operating figures show a sharper split between revenue and earnings.
Revenue slips while EPS beats
In the quarter reported on August 5, 2026, Charles River Laboratories generated USD 1 billion in revenue, down 2.7 percent year over year, according to MarketBeat. Adjusted EPS reached USD 3.02 against a consensus estimate of USD 2.77, producing a USD 0.25 beat, while the prior-year figure was USD 3.12.
The combination matters because the revenue decline and the earnings beat point in different directions. Charles River Laboratories converted a smaller top line into adjusted earnings that exceeded expectations, but the USD 0.10 year-over-year EPS decline keeps cost control and demand recovery central to the valuation discussion.
Analyst target reaches USD 320
Evercore ISI maintained an Outperform rating and lifted its price target from USD 300 to USD 320 on September 11, 2026, as reported by Yahoo Finance. The new target sits 11.9 percent above the September 23 intraday price, creating a concrete benchmark against the stock's current level.
MarketBeat also reported fiscal 2026 adjusted EPS guidance of USD 11.15 to USD 11.45. That range gives investors a clearer earnings yardstick than the revenue trend alone, particularly because the latest quarter produced positive adjusted earnings alongside a year-over-year sales decline.
Stock remains below yearly high
Charles River Laboratories had a market capitalization of USD 13,772,831,300 on September 23, 2026. Its intraday gain of 0.29 percent was modest beside the 5.7 percent gap to the 52-week high, leaving the stock close to its upper yearly territory but short of a fresh high.
Charles River Laboratories market snapshot
- Company: Charles River Laboratories International, Inc.
- Ticker: CRL
- Trading venue: NYSE
- Price (September 23, 2026, 11:35 a.m. ET): USD 285.94
- Market capitalization: USD 13,772,831,300 (as of September 23, 2026)
- 52-week range: USD 144.26-303.31 (as of September 23, 2026)
- Sector / Industry: Healthcare / Medical - Diagnostics & Research
